Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Vart

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Diabetes, Obesity & Metabolism|August 14, 2023
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trialsHiddo J L Heerspink, Priya Vart, Niels Jongs, et al.
Diabetes, Obesity & Metabolism|January 5, 2022
Quételet (body mass) index and effects of dapagliflozin in chronic kidney diseaseGlenn M Chertow, Priya Vart, Niels Jongs, et al.
Journal of the American Society of Nephrology : JASN|July 18, 2025
Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKDWisanne M Bakker, Hiddo J L Heerspink, Niels Jongs, et al.
American Heart Journal|February 17, 2024
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and AlbuminuriaHiddo Jl Heerspink, Michele Provenzano, Priya Vart, et al.
Journal of the American College of Cardiology|February 12, 2021
Absolute Coronary Blood Flow Measured by Continuous Thermodilution in Patients With Ischemia and Nonobstructive DiseaseRegina E Konst, Suzette E Elias-Smale, Dario Pellegrini, et al.
Journal of General Internal Medicine|December 15, 2023
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by SexMargaret K Yu, Priya Vart, Niels Jongs, et al.
Clinical Transplantation|December 5, 2024
Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant RejectionLukas K van Vugt, Erzsi Tegzess, Marieke van der Zwan, et al.
European Heart Journal|May 13, 2022
Timing of cardiac surgery during pregnancy: a patient-level meta-analysisGijs J van Steenbergen, Queeny H Y Tsang, Olivier W H van der Heijden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2023
Urinary albumin excretion and cancer risk: the PREVEND cohort studyLi Luo, Lyanne M Kieneker, Bert van der Vegt, et al.
Clinical Kidney Journal|January 12, 2024
Mediators of the association between albuminuria and incident cancer: the PREVEND studyLi Luo, Priya Vart, Lyanne M Kieneker, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Diabetes, Obesity & Metabolism|August 14, 2023
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trialsHiddo J L Heerspink, Priya Vart, Niels Jongs, et al.
Diabetes, Obesity & Metabolism|January 5, 2022
Quételet (body mass) index and effects of dapagliflozin in chronic kidney diseaseGlenn M Chertow, Priya Vart, Niels Jongs, et al.
Journal of the American Society of Nephrology : JASN|July 18, 2025
Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKDWisanne M Bakker, Hiddo J L Heerspink, Niels Jongs, et al.
American Heart Journal|February 17, 2024
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and AlbuminuriaHiddo Jl Heerspink, Michele Provenzano, Priya Vart, et al.
Journal of the American College of Cardiology|February 12, 2021
Absolute Coronary Blood Flow Measured by Continuous Thermodilution in Patients With Ischemia and Nonobstructive DiseaseRegina E Konst, Suzette E Elias-Smale, Dario Pellegrini, et al.
Journal of General Internal Medicine|December 15, 2023
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by SexMargaret K Yu, Priya Vart, Niels Jongs, et al.
Clinical Transplantation|December 5, 2024
Multicenter, Real-World Clinical Evaluation of Alemtuzumab and Anti-Thymocyte Globulin for Severe Acute T Cell-Mediated Kidney Transplant RejectionLukas K van Vugt, Erzsi Tegzess, Marieke van der Zwan, et al.
European Heart Journal|May 13, 2022
Timing of cardiac surgery during pregnancy: a patient-level meta-analysisGijs J van Steenbergen, Queeny H Y Tsang, Olivier W H van der Heijden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2023
Urinary albumin excretion and cancer risk: the PREVEND cohort studyLi Luo, Lyanne M Kieneker, Bert van der Vegt, et al.
Clinical Kidney Journal|January 12, 2024
Mediators of the association between albuminuria and incident cancer: the PREVEND studyLi Luo, Priya Vart, Lyanne M Kieneker, et al.
Pageof 13